Stay updated on DTG/3TC in HIV-1 Adolescents Clinical Trial
Sign up to get notified when there's something new on the DTG/3TC in HIV-1 Adolescents Clinical Trial page.

Latest updates to the DTG/3TC in HIV-1 Adolescents Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference2%

- Check35 days agoChange DetectedVersion upgrade from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.0%

- Check49 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

- Check56 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

- Check64 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with relevant publications related to HIV treatment, specifically focusing on the efficacy and safety of Dolutegravir in adolescents. Additionally, the revision number has been updated to reflect the latest version.SummaryDifference2%

- Check78 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%

Stay in the know with updates to DTG/3TC in HIV-1 Adolescents Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DTG/3TC in HIV-1 Adolescents Clinical Trial page.